In 77 of 114 consecutive patients with suspected hepatobiliary disease undergoing cholescintigraphy a firm clinical or operative diagnosis was possible. These patients were classified as normal, or as having extra-hepatic biliary obstruction (partial or complete) or hepatocellular disease. On a double-blind basis cholescintigraphy correctly interpreted 18 of 20 (90%) normal controls, 12 of 14 (86%) of those with partial obstruction, 16 of 16 (100%) of those with complete obstruction and 23 of 27 (85%) of those with hepatocellular disease giving an overall diagnostic accuracy of 69 of 77 (90%). There were no complications or toxic reactions. Ninety-three percent of patients with biliary obstruction (sensitivity) and 87% of those without biliary obstruction (specificity) were correctly diagnosed. Cholescintigraphy is a non-invasive, cheap and reliable investigation which can be used in the presence of icterus to discriminate between patients with and without extra-hepatic biliary obstruction. In contrast to grey scale ultrasonography the production and interpretation of scans are simple. Moreover cholescintigraphy adds a functional element to the investigation of liver disease.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Baker RJ, Bellen JC, Ronai PM (1975) Technetium 99m-pryridoxylidene-glutamate: a new hepatobiliary radiopharmaceutical 1. Experimental espects. JNM 16:720–727
Baker RJ, Marion MA (1977) Biliary scanning with Tc-99m pyridoxylidene-glutamate—The effect of food in normal subjects: concise communication. JNM 18:793–795
Eikman EA, Cameron JL, Colman M, Nataragan TK, Dugal P, Wager HN (1975) A test for potency of the cystic duct in acute cholecystitis. Ann Intern Med 82:318–322
Elias E (1976) Progress report. Cholangiography in the jaundiced patient. Gut 17:801–811
Jenner RE, Howard ER, Clarke MB, Barrett JJ (1978) Hepatobiliary imaging: a comparison of 99Tcm-dihydrothioctic acid and 99 Tcm-pyridoxylidene glutamate in the non-jaundiced patient. Br J Radiol 51:858–861
Jenner RE, Howard ER, Clarke MB, Barrett JJ (1978) Hepatobiliary imaging: the use of 99Tcm-pyridoxylidene glutamate scanning in jaundiced adults and infants. Br J Radiol 51:862–866
Lubin E, Rachima M, Oren V, Weininger J, Trumper J, Kazenitzky I, Rechnic Y (1978) Tc-99m pyridoxylidene glutamate in jaundiced patients. JNM 19:24–27
Matolo NM, Stadalnik RC, Wolfman EF Jr (1977) Hepatobiliary scanning 99mTc-pyridoxylideneglutamate. Am J Surg 133:116–120
McNeil BJ, Keller E, Adelstein SJ (1975) Primer on certain elements of medical decision making. N Engl J Med 293:211–215
Poulose KP, Eckelman WC, Reba RC, Goodyear M (1976) Evaluation of 99mTc-pyridoxylideneglutamate for the differential diagnosis of jaundice. Clin Nuc Med 1:70–72
Ronai PM, Baker RJ, Bellen JC, Collins PJ, Anderson PJ, Lander H (1975) Technetium-99m pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. 11. Clinical aspects. NM 16:728–737
Rosenthall L, Shaffer EA, Lisbona R, Pare P (1978) Diagnosis of hepatobiliary disease by 99mTc-HIDA cholescintigraphy. Radiology 126:467–474
Stadalnik RC, Matolo NM, Jansholt AL, Krohn KA, Denardo GL, Wolfman EF Jr (1976) Technetium-99, pyridoxylideneglutamate (PG). Radiology 121:657–661
Williams JAR, Baker RJ, Walsh JF, Marion MA (1977) The role of biliary scanning in the investigation of the surgically jaundiced patient. Surg Gynecol Obstet 144:525–530
Wistow BW, Subramanian G, Heertum RL Van, Henderson RW, Gagne GM, Hall RC, McAfee JG (1977) An evaluation of 99m Tc-labelled hepatobiliary agents. JNM 18:455–461
About this article
Cite this article
Clarke, D.N., Sharp, P.F., Brunt, P.W. et al. Hepatobiliary imaging using Tc-pyridoxylideneglutamate in the diagnosis of obstructive jaundice. Eur J Nucl Med 7, 370–375 (1982). https://doi.org/10.1007/BF00255656
- Liver Disease
- Nuclear Medicine
- Normal Control
- Diagnostic Accuracy
- Grey Scale